+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Mucopolysaccharidosis II (MPS II) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Mucopolysaccharidosis II (MPS II) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • March 2023
  • 64 Pages
  • Global
From
Ulcerative Colitis Epidemiology Analysis and Forecast, 2021-2031 - Product Thumbnail Image

Ulcerative Colitis Epidemiology Analysis and Forecast, 2021-2031

  • Report
  • February 2023
  • 48 Pages
  • Global
From
Systemic Lupus Erythematosus and Lupus Nephritis Epidemiology Analysis and Forecast, 2021-2031 - Product Thumbnail Image

Systemic Lupus Erythematosus and Lupus Nephritis Epidemiology Analysis and Forecast, 2021-2031

  • Report
  • February 2023
  • 59 Pages
  • Global
From
Regenerative Medicine in Pharma Market Size, Share and Trends Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical), and Segment Forecast, 2022-2027 - Product Thumbnail Image

Regenerative Medicine in Pharma Market Size, Share and Trends Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical), and Segment Forecast, 2022-2027

  • Report
  • November 2022
  • 119 Pages
  • Global
From
Atopic Dermatitis Market Size, Share and Trends Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical) and Segment Forecast, 2022-2027 - Product Thumbnail Image

Atopic Dermatitis Market Size, Share and Trends Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical) and Segment Forecast, 2022-2027

  • Report
  • November 2022
  • 107 Pages
  • Global
From
Axial Spondyloarthritis (axSpA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Axial Spondyloarthritis (axSpA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • October 2022
  • 82 Pages
  • Global
From
Autoimmune Hepatitis Marketed and Pipeline Drugs Assessment, Clinical Trials, and Competitive Landscape - Product Thumbnail Image

Autoimmune Hepatitis Marketed and Pipeline Drugs Assessment, Clinical Trials, and Competitive Landscape

  • Report
  • October 2022
  • 60 Pages
  • Global
From
Febrile Neutropenia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Febrile Neutropenia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • September 2022
  • 176 Pages
  • Global
From
Sjogrens Syndrome Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Sjogrens Syndrome Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • July 2022
  • 59 Pages
  • Global
From
Plaque Psoriasis - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Plaque Psoriasis - Global Drug Forecast and Market Analysis to 2030

  • Report
  • November 2021
  • 108 Pages
  • Global
From
Rheumatoid Arthritis - Epidemiology Forecast to 2029 - Product Thumbnail Image

Rheumatoid Arthritis - Epidemiology Forecast to 2029

  • Report
  • November 2020
  • 46 Pages
  • Global
From
Graft-Versus-Host Disease: Epidemiology Forecast in Asia-Pacific Markets to 2028 - Product Thumbnail Image

Graft-Versus-Host Disease: Epidemiology Forecast in Asia-Pacific Markets to 2028

  • Report
  • February 2020
  • 44 Pages
  • Asia Pacific
From
Alopecia Areata: Epidemiology Forecast to 2028 - Product Thumbnail Image

Alopecia Areata: Epidemiology Forecast to 2028

  • Report
  • July 2019
  • 31 Pages
  • Global
From
Plaque Psoriasis: Seven-Market Drug Forecast and Market Analysis - Update - Product Thumbnail Image

Plaque Psoriasis: Seven-Market Drug Forecast and Market Analysis - Update

  • Report
  • September 2024
  • 115 Pages
  • Global
From
Gout - Opportunity Assessment and Forecast - Product Thumbnail Image

Gout - Opportunity Assessment and Forecast

  • Report
  • December 2023
  • 62 Pages
  • Global
From
Insomnia - Opportunity Assessment and Forecast - Product Thumbnail Image

Insomnia - Opportunity Assessment and Forecast

  • Report
  • December 2023
  • 67 Pages
  • Global
From
Gaucher Disease - Opportunity Assessment and Forecast - Product Thumbnail Image

Gaucher Disease - Opportunity Assessment and Forecast

  • Report
  • December 2023
  • 59 Pages
  • Global
From
Systemic Lupus Erythematosus and Lupus Nephritis: Global Drug Forecast and Market Analysis to 2027 - Product Thumbnail Image

Systemic Lupus Erythematosus and Lupus Nephritis: Global Drug Forecast and Market Analysis to 2027

  • Report
  • February 2020
  • 163 Pages
  • Global
From
United Kingdom - Medicaments Containing Corticosteroid Hormones - Market Analysis, Forecast, Size, Trends and Insights - Product Thumbnail Image

United Kingdom - Medicaments Containing Corticosteroid Hormones - Market Analysis, Forecast, Size, Trends and Insights

  • Report
  • November 2025
  • United Kingdom
From
Sicca Syndrome Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Sicca Syndrome Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • September 2024
  • 110 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more